25546-65-0
Chemical Structure
Ribostamycin
Synonym(s): Vistamycin; SF-733
- CAS No.: 25546-65-0
- Formula:C17H34N4O10
- Molecular Weight:454.47
IUPAC Name: (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-(((1R,2R,3S,4R,6S)-4,6-diamino-2-(((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-3-hydroxycyclohexyl)oxy)tetrahydro-2H-pyran-3,4-diol
InChIKey: NSKGQURZWSPSBC-VVPCINPTSA-N
SMILES: NC[C@H]([C@H]([C@@H]([C@H]1N)O)O)O[C@@H]1O[C@H]([C@H](C[C@H]([C@@H]2O)N)N)[C@@H]2O[C@@H]3O[C@@H]([C@H]([C@H]3O)O)CO
Biological Activity: Ribostamycin (Vistamycin) is a broad-spectrum aminoglycoside antibiotic. Ribostamycin is effective against Gram-Negative and Gram-Positive bacterial infection. Ribostamycin also inhibits the chaperone activity of PDI[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ribostamycin | 99.89% | Ribostamycin (Vistamycin) is a broad-spectrum aminoglycoside antibiotic. Ribostamycin is effective against Gram-Negative and Gram-Positive bacterial infection. Ribostamycin also inhibits the chaperone activity of PDI. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2-(α-D-Mannopyranosyl)-L-tryptophan-d4 | 2-(α-D-Mannopyranosyl)-L-tryptophan-d4 is the deuterium labeled 2-(α-D-Mannopyranosyl)-L-tryptophan. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.93
HY-B1228Ribostamycin sulfate -
Similarity Score 0.87
HY-1803283''-Deamino-3''-hydroxykanamycin B -
Similarity Score 0.85
HY-B1174Bekanamycin -
Similarity Score 0.82
HY-16566Kanamycin -
Similarity Score 0.81
HY-B0956AParomomycin -
Similarity Score 0.81
HY-N147566"'-Deamino-6"'-hydroxyneomycin B -
Similarity Score 0.81
HY-Z16212Neomycin F -
Similarity Score 0.80
HY-B1174ABekanamycin sulfate -
Similarity Score 0.80
HY-131130Neomycin C -
Explore the MedChemAI to find more analogs
References
- [1]. Zheng T, et al. Linear self-assembly formation between gold nanoparticles and aminoglycoside antibiotics. Colloids Surf B Biointerfaces. 2018 Apr 1;164:185-191. [Content Brief]
- [2]. Hunfeld KP, et al. In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi. Int J Antimicrob Agents. 2001 Mar;17(3):203-8. [Content Brief]
